Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Matrix metalloproteinases and their tissue inhibitors after selective laser trabeculoplasty in pseudoexfoliative secondary glaucoma.

Cellini M, Leonetti P, Strobbe E, Campos EC.

BMC Ophthalmol. 2008 Oct 21;8:20. doi: 10.1186/1471-2415-8-20.

2.

[Selective laser trabeculoplasty in glaucoma treatment--results during three years follow-up].

Sicáková S, Výborný P.

Cesk Slov Oftalmol. 2010 Nov;66(5):204-8. Czech.

PMID:
21394976
3.

Selective laser trabeculoplasty in uncontrolled pseudoexfoliation glaucoma.

Goldenfeld M, Geyer O, Segev E, Kaplan-Messas A, Melamed S.

Ophthalmic Surg Lasers Imaging. 2011 Sep-Oct;42(5):390-3. doi: 10.3928/15428877-20110630-01. Epub 2011 Jul 7.

PMID:
21732569
4.

Transforming growth factor beta1, matrix-metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation glaucoma/syndrome.

Djordjević-Jocić J, Zlatanović G, Veselinović D, Jovanović P, Djordjević V, Zvezdanović L, Stanković-Babić G, Vujanović M, Cekić S, Zenkel M, Schlotzer-Schrehardt U.

Vojnosanit Pregl. 2012 Mar;69(3):231-6.

PMID:
22624408
5.

Selective laser trabeculoplasty following failed combined phacoemulsification cataract extraction and ab interno trabeculectomy.

Töteberg-Harms M, Rhee DJ.

Am J Ophthalmol. 2013 Nov;156(5):936-940.e2. doi: 10.1016/j.ajo.2013.05.044. Epub 2013 Aug 7.

PMID:
23932217
6.

TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.

Ashworth Briggs EL, Toh T, Eri R, Hewitt AW, Cook AL.

Mol Vis. 2015 Oct 13;21:1162-72. eCollection 2015.

7.

Correlation of endothelin-1 concentration in aqueous humor with intraocular pressure in primary open angle and pseudoexfoliation glaucoma.

Choritz L, Machert M, Thieme H.

Invest Ophthalmol Vis Sci. 2012 Oct 23;53(11):7336-42. doi: 10.1167/iovs.12-10216.

PMID:
23036995
8.

A randomized clinical trial of selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with pseudoexfoliation.

Kent SS, Hutnik CM, Birt CM, Damji KF, Harasymowycz P, Si F, Hodge W, Pan I, Crichton A.

J Glaucoma. 2015 Jun-Jul;24(5):344-7. doi: 10.1097/IJG.0b013e31829e55e4.

PMID:
23835670
9.

Inflammation assessment after selective laser trabeculoplasty (SLT) treatment.

Ayala M, Landau Högbeck I, Chen E.

Acta Ophthalmol. 2011 Jun;89(4):e306-9. doi: 10.1111/j.1755-3768.2010.02029.x. Epub 2011 Mar 22.

10.

[Combined phacoemulsification and goniotrephination in primary open-angle glaucoma and pseudoexfoliation glaucoma - a retrospective analysis].

Heuring AH, Hütz WW, Eckhardt HB.

Klin Monbl Augenheilkd. 2001 Aug;218(8):535-41. German.

PMID:
11573154
11.

Selective laser trabeculoplasty in the treatment of open-angle glaucoma.

Koucheki B, Hashemi H.

J Glaucoma. 2012 Jan;21(1):65-70. doi: 10.1097/IJG.0b013e3182027596.

PMID:
21278588
12.

Efficacy of selective laser trabeculoplasty in primary angle-closure glaucoma: a randomized clinical trial.

Narayanaswamy A, Leung CK, Istiantoro DV, Perera SA, Ho CL, Nongpiur ME, Baskaran M, Htoon HM, Wong TT, Goh D, Su DH, Belkin M, Aung T.

JAMA Ophthalmol. 2015 Feb;133(2):206-12. doi: 10.1001/jamaophthalmol.2014.4893.

PMID:
25429421
13.

Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma.

Schlötzer-Schrehardt U, Lommatzsch J, Küchle M, Konstas AG, Naumann GO.

Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1117-25.

PMID:
12601038
14.

Comparison of the efficacy and safety of selective laser trabeculoplasty in cases with primary open-angle glaucoma and pseudoexfoliative glaucoma.

Kara N, Altan C, Yuksel K, Tetikoglu M.

Kaohsiung J Med Sci. 2013 Sep;29(9):500-4. doi: 10.1016/j.kjms.2013.01.005. Epub 2013 Apr 6.

15.

Selective laser trabeculoplasty in the treatment of pseudoexfoliation glaucoma in patients allergic to all anti-glaucoma drops.

Gavrić M, Gabrić N, Dekaris I, Bohać M, Draca N.

Coll Antropol. 2010 Apr;34 Suppl 2:275-7.

PMID:
21302732
16.

Selective Laser Trabeculoplasty in Primary Angle-closure Glaucoma After Laser Peripheral Iridotomy: A Case-Control Study.

Ali Aljasim L, Owaidhah O, Edward DP.

J Glaucoma. 2016 Mar;25(3):e253-8. doi: 10.1097/IJG.0000000000000282.

PMID:
26945310
17.

Repeat selective laser trabeculoplasty.

Hong BK, Winer JC, Martone JF, Wand M, Altman B, Shields B.

J Glaucoma. 2009 Mar;18(3):180-3. doi: 10.1097/IJG.0b013e31817eee0b.

18.

Influence of Selective Laser Trabeculoplasty (SLT) on combined clear cornea phacoemulsification and Trabectome outcomes.

Klamann MK, Gonnermann J, Maier AK, Bertelmann E, Joussen AM, Torun N.

Graefes Arch Clin Exp Ophthalmol. 2014 Apr;252(4):627-31. doi: 10.1007/s00417-014-2569-7. Epub 2014 Jan 12.

PMID:
24413683
19.

Anti-inflammatory therapy after selective laser trabeculoplasty: a randomized, double-masked, placebo-controlled clinical trial.

Jinapriya D, D'Souza M, Hollands H, El-Defrawy SR, Irrcher I, Smallman D, Farmer JP, Cheung J, Urton T, Day A, Sun X, Campbell RJ.

Ophthalmology. 2014 Dec;121(12):2356-61. doi: 10.1016/j.ophtha.2014.07.017. Epub 2014 Sep 16.

PMID:
25234015
20.

Mechanism of Action of Selective Laser Trabeculoplasty and Predictors of Response.

Gulati V, Fan S, Gardner BJ, Havens SJ, Schaaf MT, Neely DG, Toris CB.

Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1462-1468. doi: 10.1167/iovs.16-20710.

Supplemental Content

Support Center